DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 05 · Volume 71 · 1994 DOI: 10.1055/s-009-45160

Review Article

  • 533
  • 544
  • 548
    Pabinger, Ingrid; Schneider, Barbara; The GTH Study Group on Natural Inhibitors; GTH (Gesellschaft für Thrombose- und Hämostaseforschung) Study Group on Natural Inhibitors:; Scharrer, I; Hach-Wunderle, V; Lechner, K; Eichinger, S; Kyrle, P A; Vinazzer, H; Lämmle, B; Demarmels-Biasiutti, F; Tilsner, V; Marx, G; Scifricd, E; Gabelmann, A; Aspöck, G; Fischer, M; Halbmaycr, W M:

    Thrombotic Risk of Women with Hereditary Antithrombin III-, Protein C- and Protein S-Deficiency Taking Oral Contraceptive Medication

  • 553
    Imbimbo, B P; Sié, P; Agnelli, G; Saivin, S; Dupouy, D; Damiani, M; Houin, G; Gianese, F:

    Intramuscular Dermatan Sulfate MF701 in Patients with Hip Fracture: Relationship between Pharmacokinetics and Antithrombotic Efficacy

  • 558
    Schiele, F; Vuillemenot, A; Kramarz, Ph; Kieffer, Y; Soria, J; Soria, C; Camez, A; Mirshahi, M C; Bassand, J P:

    A Pilot Study of Subcutaneous Recombinant Hirudin (HBW 023) in the Treatment of Deep Vein Thrombosis

  • 563
    Saad, S; Rowley, G; Tagliavacca, L; Green, P M; Giannelli, F; and UK haemophilia centres:

    First Report on UK Database of Haemophilia B Mutations and Pedigrees

  • 571
  • 576
  • 581
    Giansante, Carlo; Fiotti, Nicola; Cattin, Luigi; Col, Paolo Giovanni Da; Calabrese, Salvatore:

    Fibrinogen, D-Dimer and Thrombin-Antithrombin Complexes in a Random Population Sample: Relationships with Other Cardiovascular Risk Factors

  • 587
    Kumar, Anuradha; Koenig, Kathleen B; Johnson, Alice R; Idell, Steven:

    Expression and Assembly of Procoagulant Complexes by Human Pleural Mesothelial Cells

  • 593
    Ceriello, Antonio; Pirisi, Mario; Giacomello, Roberta; Stel, Giuliana; Falleti, Edmondo; Motz, Enrico; Lizzio, Sebastiano; Gonano, Fabio; Bartoli, Ettore:

    Fibrinogen Plasma Levels as a Marker of Thrombin Activation: New Insights on the Role of Fibrinogen as a Cardiovascular Risk Factor

  • 596
  • 605
  • 609
    Korutla, Laxminarayana N; Stewart, Gwendolyn J; Lasz, Elizabeth C; Maione, Theodore E; Niewiarowski, Stefan:

    Evaluation of Recombinant Platelet Factor 4 and Protamine Sulfate for Heparin Neutralization: Clotting and Clearance Studies in Rat

  • 615
    Váradi, Katalin; Philapitsch, Anton; Santa, Thomas; Schwarz, Hans Peter:

    Activation and Inactivation of Human Protein C by Plasmin

  • 622
    Beer, J H; Kläy, H P; Herren, T; Haeberli, A; Straub, P W:

    Whole Blood Clot Lysis: Enhanced by Exposure to Autologous but not to Homologous Plasma

  • 627
    Katzman, Per L; Bose, Ratna; Henry, Stephen; McLean, Donna L; Walker, Shaun; Fyfe, Christopher; Perry, Yvette; Mymin, David; Bolli, Peter:

    Serum Lipid Profile Determines Platelet Reactivity to Native and Modified LDL-Cholesterol in Humans

  • 633
    Michelson, Alan D; MacGregor, Hollace; Barnard, Marc R; Kestin, Anita S; Rohrer, Michael J; Robert Valeri, C:

    Reversible Inhibition of Human Platelet Activation by Hypothermia In Vivo and In Vitro

  • 641
  • 646
    Nystrom, M L; Barradas, M A; Jeremy, J Y; Mikhailidis, D P:

    Platelet Shape Change in Whole Blood: Differential Effects of Endotoxin

  • 651
    Kalb, Rainer; Santoso, Sentot; Unkelbach, Katja; Kiefel, Volker; Mueller-Eckhardt, Christian:

    Localization of the Br Polymorphism on a 144 bp Exon of the GPIa Gene and Its Application in Platelet DNA Typing

  • 655
    Roald, Helge E; Marius Barstad, R; Kierulf, Peter; Skjørten, Fredrik; Dickinson, John P; Kieffer, Gilles; Sakariassen, Kjell S:

    Clopidogrel – a Platelet Inhibitor which Inhibits Thrombogenesis in Non-Anticoagulated Human Blood Independently of the Blood Flow Conditions

  • 663
    Samama, Ch M; Mazoyer, E; Bruneval, P; Ciostek, P; Bonnin, Ph; Bonneau, M; Roussi, J; Bailliart, O; Pignaud, G; Viars, P; Caen, J P; Drouet, L O:

    Aprotinin Could Promote Arterial Thrombosis in Pigs: a Prospective Randomized, Blind Study

  • 670
    Pierangeli, Silvia S; Barker, John H; Stikovac, Dejzi; Ackerman, Douglas; Anderson, Gary; Barquinero, Jordi; Acland, Robert; Nigel Harris, E:

    Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice

  • 675
    Kemahli, Sabri; Canatan, Duran; Uysal, Zümrüt; Akar, Nejat; Cin, Sükrü; Arcasoy, Ayten:

    DDAVP Shortens Bleeding Time in Bernard-Soulier Syndrome

  • 676
  • 678
  • 684
    Damjanovich, László; Turzó, Csaba; Ádány, Róza:

    Factors Involved In the Plasminogen Activation System in Human Breast Tumours

  • 692
    Knöbl, Paul; Schernthaner, Guntram; Schnack, Christoph; Pietschmann, Peter; Proidl, Sylvia; Prager, Rudolf; Vukovich, Thomas:

    Haemostatic Abnormalities Persist Despite Glycaemic Improvement by Insulin Therapy in Lean Type 2 Diabetic Patients

  • 698
    Alhenc-Gelas, M; Guernic, C Jestin-Le; Vitoux, J F; Kher, A; Aiach, M; Fiessinger, J N; Fragmin-Study Group:

    Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis

  • 703
    Mauser-Bunschoten, E P; Rosendaal, F R; Nieuwenhuis, H K; Roosendaal, G; Briëf, E; van den Berg, H M:

    Clinical Course of Factor VIII Inhibitors Developed after Exposure to a Pasteurised Dutch Concentrate Compared to Classic Inhibitors in Hemophilia A

  • 707
    Moor, Elisabeth; Hamsten, Anders; Karpe, Fredrik; Båvenholm, Peter; Blombäck, Margareta; Silveira, Angela:

    Relationship of Tissue Factor Pathway Inhibitor Activity to Plasma Lipoproteins and Myocardial Infarction at a Young Age

  • 713
    Rahr, H B; Sørensen, J V; Larsen, J F; Svendsen Jensen, F; Bredahl, C; Nieuwenhuizen, W:

    Haemostatic Activation before and after Surgery in Patients with and without Gastric Malignancy